Sotatercept was recently approved by the Food and Drug Administration (FDA) to treat adults with pulmonary arterial hypertension (PAH) after completing a Phase 3 clinical trial at Norton Pulmonary Specialists and other leading pulmonary hypertension centers. Sotatercept, sold under the brand name Winrevair, is a new class of therapy for pulmonary arterial hypertension. It has…
Artificial intelligence (AI) like ChatGPT can compose essays or emails, write computer code, even generate art, but how well can it manage complex patient care? A team that included Norton Healthcare researchers decided to find out. They compared ChatGPT’s recommendations for managing an 81-year-old patient with nonresolving pneumonia with those of a pulmonary specialist. “What…
Dana L. Gibson, M.D. Pediatrics Richard E. McCarthy, M.D. Pediatric Orthopedic Surgery Clinton M. Nowicke, Psy.D. Developmental-Behavioral Pediatrics Tara B. Clarke, APRN Pediatric Cardiology Jessica R. Coleman, APRN Pediatric Endocrinology Kelsie L. Houchens, APRN Pediatrics Kimberly M. Rogers, APRN Pediatric Emergency Medicine
John T. Garner, M.D. Hospital Medicine Ishan J. Parikh, D.O. Hospital Medicine Aleksandr Pevtsov, D.O. Emergency Medicine Elizabeth Fahey, PA-C Orthopedic Hand Surgery Amy Seldon, PA-C Emergency Medicine Gregory A. Hart, APRN Emergency Medicine Amy B. Hughes, APRN Emergency Medicine Kathryn A. Karem, APRN Urgent Care Jason W. Raggard, APRN Emergency Medicine Ashley R. Trautwein,…
Norton Healthcare continues its focus of expanding access to health care in Jeffersonville, Indiana. Additional emergency and diagnostic services are now available at Norton Medical Center in the Jeffersonville Commons shopping center, 2023 Mercy Way. The new center, a $17 million investment, houses a full-service emergency department and a diagnostic center in approximately 15,000 square…
Prehabilitation, or “prehab,” refers to optimizing general health and well-being before surgery to improve surgical outcomes. Prehab takes a multidisciplinary approach, focusing on strength and aerobic exercises, nutrition, smoking cessation, alcohol reduction, and psychological factors such as mitigating stress, anxiety and depression. The approach is primarily designed for patients who are at the highest risk…
Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The randomized, active-treatment trial is testing the safety, tolerability and effect of four dose levels of ANG003, a compound developed by…
The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. She developed persistent numbness and tingling in her left leg, as well as weakness. She was evaluated in the Norton…
Pamela C Biddle, M.D. Pediatrics Jessica N.B. Easterling, M.D. Pediatrics Kelly E Kries, MD Pediatrics Casey L Miles, MD Pediatrics Danielle R. Lunsford, APRN Developmental-Behavioral Pediatrics Mary C. Oechslin, APRN Pediatrics Chelsea R. Sabelhaus, APRN Neonatology
Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery Kathryn Hardesty, PA-C General Surgery Kyla M. Byard, APRN Family Medicine Stacie S. Cheney, APRN Family Medicine Anna N. Ertel,…
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the treatment of patients with mild cognitive impairment (MCI) or early stages of Alzheimer’s disease. This is the first new Alzheimer’s…
Not-for-profit Norton Healthcare and Norton Children’s ask for the community’s help to improve health and quality of life for every person in Kentucky and Southern Indiana. The organization, along with local and community leaders, announced its “Just Imagine” campaign, which aims to raise $200 million in the next two years to support investments in health care…